Midazolam is used to calm patients before medical procedures and surgeries, and to help control seizures. It works by slowing down brain activity to reduce anxiety and help people relax or fall asleep.[2] Versed is currently approved and in use across 116 indications[4].[1]
Versed is one of 1764 small molecule programs targeting Interaction. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Patents
Pipeline
Competition
744 competitors in Breast Cancer
Versed
Adenocard
Zolymbus
Methylthioninium Chloride
MS Contin
Duragesic-100
MS Contin
Spravato
Duragesic
Nubain
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
May 26, 1987
VERSED
NDA NDA018654
Oct 15, 1998
VERSED
NDA NDA020942
Sep 14, 2018
SEIZALAM
NDA NDA209566
May 17, 2019
NAYZILAM
NDA NDA211321
Mar 22, 2021
MIDAZOLAM IN 0.9% SODIUM CHLORIDE
NDA NDA211844
Jul 20, 2022
MIDAZOLAM IN 0.8% SODIUM CHLORIDE
NDA NDA215868
Aug 8, 2022
MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR)
NDA NDA216359
Sources
Details